← Back to Clinical Trials
Recruiting NCT06471842

Study of the Prevalence of Pediatric Eating Disorders in Inherited Metabolic Diseases With Dietary Treatment

Trial Parameters

Condition Inherited Metabolism Disease
Sponsor Assistance Publique - Hôpitaux de Paris
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 12 Months
Max Age 6 Years
Start Date 2024-08-21
Completion 2026-08
Interventions
MCH (Montreal Children's Hospital) feeding scale questionnaire and parental questionnaire

Brief Summary

The main objective of this study is to estimate the prevalence of Pediatric Eating Disorders (PED) in Inherited Metabolic Diseases (IMD) with dietary treatment between the age of 12 months and 6 years 11 months.

Eligibility Criteria

Inclusion Criteria: * Patient from 12 months to 6 years and 11 months old * Patient with an Inherited Metabolic Diseases with dietary treatment * Patient having experimented a dietary diversification at least 6 month prior * Patient whose parents do not object to their participation in the study Exclusion Criteria: * Patient with an associated chronic disease * Patient with diagnosed Autistic Spectrum Disorder (ASD) or Pervasive Developmental Disorders (PDD) * Patient born before 36 weeks of amenorrhea * Patient with multiple disabilities * Patient with dystonia * Patient with absent or unstable head posture * Patient whose parents do not fully understand or speak French

Related Trials